Skip Navigation
Archive

NIAID Archive

Important note: Information on this page was accurate at the time of publication. This page is no longer being updated.
​​
NIH HHS News Release Logo
National Institute of Allergy and
Infectious Diseases (NIAID)
http://www.niaid.nih.gov

FOR IMMEDIATE RELEASE
October 15, 2002

Media Contact:
(301) 402-1663
niaidnews@niaid.nih.gov
Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

USAMRIID-NIAID ANNOUNCE RESEARCH PARTNERSHIP AT FORT DETRICK

Officials from the Army and the National Institutes of Health (NIH) briefed state and local officials today on plans for a major biomedical research partnership at Fort Detrick in Frederick, Maryland.

As a result of a Congressional mandate and anticipated funding, the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) and the National Institute of Allergy and Infectious Diseases (NIAID) will become partners in conducting biodefense research. NIAID and USAMRIID have had a productive relationship over the years working on biodefense related diagnostics, drugs and vaccine research, and this effort located at Fort Detrick will uniquely marshal research capabilities while consolidating resources in response to the nation’s changing needs.

USAMRIID intends to expand its current facilities and continue its critical mission of research on drugs, vaccines and diagnostics to safeguard the health of the nation’s armed forces. As part of the need for additional, accelerated research programs in biodefense for the civilian population, NIAID plans to build a laboratory adjacent to USAMRIID.

The agencies have begun the complex process of planning and designing the new facilities, to be located at an existing secure site within Fort Detrick, and expect construction to take place over the next several years. The new NIAID facility will be a Biosafety laboratory comprised of Biosafety Level (BSL) 2, 3 and 4 areas that will allow researchers to study disease-causing microbes that may be used as agents of bioterrorism. Both NIAID and USAMRIID scientists have had extensive experience with research in BSL 3 and 4 laboratories for approximately 30 years.

Construction of new facilities will comply with the National Environmental Policy Act, which requires an assessment of potential human health and environmental impacts. Documents addressing the impacts of new construction will be available in public libraries and on the web for review and comment. Publication and community meeting dates will be announced in local newspapers.


NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at www.niaid.nih.gov.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

NIH...Turning Discovery Into Health ®

back to top


Archive

NIAID Archive

Important note: Information on this page was accurate at the time of publication. This page is no longer being updated.
​​​​

Last Updated October 15, 2002